|
Volumn 9, Issue 3, 2008, Pages 134-
|
Editorial: The therapeutic potential of ribonucleases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
CYTOTOXIN;
ENZYME;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
HYBRID PROTEIN;
LIGAND;
PANCREATIC RIBONUCLEASE;
RANPIRNASE;
RIBONUCLEASE;
RIBONUCLEASE A;
SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;
ANTIBODY SPECIFICITY;
ANTIGEN BINDING;
ANTIGEN PRESENTATION;
CANCER CHEMOTHERAPY;
CANCER INCIDENCE;
CANCER RADIOTHERAPY;
CELL SURFACE;
CELL TRANSFORMATION;
CLINICAL TRIAL;
DRUG CONJUGATION;
DRUG TARGETING;
EDITORIAL;
HUMAN;
LUNG NON SMALL CELL CANCER;
MALIGNANT MESOTHELIOMA;
RNA PROCESSING;
SOLID TUMOR;
|
EID: 47749147697
PISSN: 13892010
EISSN: 18734316
Source Type: Journal
DOI: 10.2174/138920108784567290 Document Type: Editorial |
Times cited : (3)
|
References (0)
|